Lloyd Clarke

1.1k total citations
41 papers, 816 citations indexed

About

Lloyd Clarke is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Lloyd Clarke has authored 41 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Infectious Diseases and 13 papers in Pharmacology. Recurrent topics in Lloyd Clarke's work include Antibiotic Resistance in Bacteria (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Lloyd Clarke is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Lloyd Clarke collaborates with scholars based in United States, Australia and Israel. Lloyd Clarke's co-authors include Ryan K. Shields, Cornelius J. Clancy, Brian A. Potoski, M. Hong Nguyen, Yohei Doi, M. Hong Nguyen, Deanna J. Buehrle, Ahmed Babiker, Kathleen A. Shutt and E.J. Kwak and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Lloyd Clarke

34 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd Clarke United States 16 375 345 307 202 135 41 816
Michael P. Veve United States 17 330 0.9× 319 0.9× 305 1.0× 272 1.3× 124 0.9× 76 925
Alessia Carnelutti Italy 16 325 0.9× 229 0.7× 288 0.9× 125 0.6× 186 1.4× 42 833
Giammarco Raponi Italy 18 342 0.9× 343 1.0× 276 0.9× 231 1.1× 74 0.5× 81 969
Myrto Christofidou Greece 18 342 0.9× 411 1.2× 221 0.7× 163 0.8× 110 0.8× 40 836
Daisuke Sakanashi Japan 17 368 1.0× 166 0.5× 287 0.9× 110 0.5× 104 0.8× 86 873
Twisha S Patel United States 16 439 1.2× 370 1.1× 214 0.7× 257 1.3× 257 1.9× 59 958
Rajeev Soman India 16 283 0.8× 362 1.0× 265 0.9× 140 0.7× 66 0.5× 82 797
Yi Ling Lai United States 14 392 1.0× 434 1.3× 252 0.8× 203 1.0× 219 1.6× 32 1.1k
Nancy M. Laing Canada 15 718 1.9× 446 1.3× 261 0.9× 246 1.2× 168 1.2× 20 1.2k
Caterina Campoli Italy 11 253 0.7× 337 1.0× 144 0.5× 243 1.2× 62 0.5× 33 593

Countries citing papers authored by Lloyd Clarke

Since Specialization
Citations

This map shows the geographic impact of Lloyd Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Clarke more than expected).

Fields of papers citing papers by Lloyd Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Clarke. The network helps show where Lloyd Clarke may publish in the future.

Co-authorship network of co-authors of Lloyd Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Clarke. A scholar is included among the top collaborators of Lloyd Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Clarke. Lloyd Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Lloyd, et al.. (2025). Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia. Antimicrobial Agents and Chemotherapy. 70(2). e0130325–e0130325.
2.
Shah, Sunish, et al.. (2025). Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infections. Infection. 53(4). 1483–1489.
3.
Shah, Sunish, Kathleen K. Adams, Lloyd Clarke, et al.. (2024). Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections. International Journal of Antimicrobial Agents. 65(3). 107403–107403.
4.
Shah, Sunish, Ellen G Kline, Ghady Haidar, et al.. (2024). Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia. Clinical Infectious Diseases. 80(1). 24–28. 9 indexed citations
5.
Shah, Sunish, Lloyd Clarke, Matthew W. Davis, Jeffrey Topal, & Ryan K. Shields. (2024). Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis. Journal of Antimicrobial Chemotherapy. 79(8). 2017–2021. 2 indexed citations
6.
Clarke, Lloyd, et al.. (2024). Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents. Antimicrobial Agents and Chemotherapy. 68(10). e0087024–e0087024. 2 indexed citations
7.
O’Donnell, Matthew, Ryan K. Shields, Rachel V Marini, et al.. (2023). Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock. Open Forum Infectious Diseases. 10(11). ofad538–ofad538. 8 indexed citations
9.
Shah, Sunish, Lloyd Clarke, & Ryan K. Shields. (2023). Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis. Open Forum Infectious Diseases. 10(3). ofad052–ofad052. 11 indexed citations
10.
Nowalk, Mary Patricia, Theresa M. Sax, Michael Susick, et al.. (2023). Effect of mild COVID-19 on health-related quality of life. Brain Behavior & Immunity - Health. 28. 100596–100596.
11.
Zimmerman, Richard K., G.K. Balasubramani, Lloyd Clarke, et al.. (2022). Population‐based hospitalization burden estimates for respiratory viruses, 2015–2019. Influenza and Other Respiratory Viruses. 16(6). 1133–1140. 22 indexed citations
12.
Balasubramani, G.K., Mary Patricia Nowalk, Lloyd Clarke, et al.. (2021). Using capture‐recapture methods to estimate influenza hospitalization incidence rates. Influenza and Other Respiratory Viruses. 16(2). 308–315. 4 indexed citations
13.
Babiker, Ahmed, Daniel R. Evans, M. Patrick Griffith, et al.. (2020). Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades. Journal of Clinical Microbiology. 58(9). 23 indexed citations
14.
Shields, Ryan K., et al.. (2017). Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria. PLoS ONE. 12(3). e0173286–e0173286. 50 indexed citations
15.
Clancy, Cornelius J., Lloyd Clarke, Ryan K. Shields, et al.. (2016). Surgical Site Infections After Liver Transplantation. Transplantation. 100(10). 2107–2114. 64 indexed citations
16.
Eschenauer, Gregory, M. Hong Nguyen, Shmuel Shoham, et al.. (2014). Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates. Antimicrobial Agents and Chemotherapy. 58(4). 1897–1906. 54 indexed citations
17.
Eschenauer, Gregory, E.J. Kwak, Abhinav Humar, et al.. (2014). Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients. American Journal of Transplantation. 15(1). 180–189. 56 indexed citations
18.
Qureshi, Zubair, Alveena Syed, Lloyd Clarke, Yohei Doi, & Ryan K. Shields. (2014). Epidemiology and Clinical Outcomes of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria. Antimicrobial Agents and Chemotherapy. 58(6). 3100–3104. 27 indexed citations
19.
Fukuta, Yuriko, Robert R. Muder, Mounzer Agha, et al.. (2013). Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. American Journal of Infection Control. 41(12). 1249–1252. 37 indexed citations
20.
Potoski, Brian A., Jennifer Adams, Lloyd Clarke, et al.. (2006). Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative Staphylococci. Clinical Infectious Diseases. 43(2). 165–171. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026